Literature DB >> 15917473

Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures.

Robert Passier1, Dorien Ward-van Oostwaard, Jolanda Snapper, Jantine Kloots, Rutger J Hassink, Ewart Kuijk, Bernard Roelen, Aart Brutel de la Riviere, Christine Mummery.   

Abstract

Human embryonic stem cells (hESCs) can differentiate into cardiomyocytes, but the efficiency of this process is low. We routinely induce cardiomyocyte differentiation of the HES-2 cell line by coculture with a visceral endoderm-like cell line, END-2, in the presence of 20% fetal calf serum (FCS). In this study, we demonstrate a striking inverse relationship between cardiomyocyte differentiation and the concentration of FCS during HES-2-END-2 coculture. The number of beating areas in the cocultures was increased 24-fold in the absence of FCS compared with the presence of 20% FCS. An additional 40% increase in the number of beating areas was observed when ascorbic acid was added to serum-free cocultures. The increase in serum-free cocultures was accompanied by increased mRNA and protein expression of cardiac markers and of Isl1, a marker of cardiac progenitor cells. The number of beating areas increased up to 12 days after initiation of coculture of HES-2 with END-2 cells. However, the number of alpha-actinin-positive cardiomyocytes per beating area did not differ significantly between serum-free cocultures (503 +/- 179; mean +/- standard error of the mean) and 20% FCS cocultures (312 +/- 227). The stimulating effect of serum-free coculture on cardiomyocyte differentiation was observed not only in HES-2 but also in the HES-3 and HES-4 cell lines. To produce sufficient cardiomyocytes for cell replacement therapy in the future, upscaling cardiomyocyte formation from hESCs is essential. The present data provide a step in this direction and represent an improved in vitro model, without interfering factors in serum, for testing other factors that might promote cardiomyocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15917473     DOI: 10.1634/stemcells.2004-0184

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  96 in total

1.  NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes.

Authors:  David A Elliott; Stefan R Braam; Katerina Koutsis; Elizabeth S Ng; Robert Jenny; Ebba L Lagerqvist; Christine Biben; Tanya Hatzistavrou; Claire E Hirst; Qing C Yu; Rhys J P Skelton; Dorien Ward-van Oostwaard; Sue Mei Lim; Ouda Khammy; Xueling Li; Susan M Hawes; Richard P Davis; Adam L Goulburn; Robert Passier; Owen W J Prall; John M Haynes; Colin W Pouton; David M Kaye; Christine L Mummery; Andrew G Elefanty; Edouard G Stanley
Journal:  Nat Methods       Date:  2011-10-23       Impact factor: 28.547

Review 2.  Stem cell therapy for ischemic heart disease.

Authors:  Mohammad Nurulqadr Jameel; Jianyi Zhang
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

Review 3.  Stem cells and cardiac repair: a critical analysis.

Authors:  Jonathan H Dinsmore; Nabil Dib
Journal:  J Cardiovasc Transl Res       Date:  2008-01-31       Impact factor: 4.132

Review 4.  Heart repair and stem cells.

Authors:  Linda W van Laake; Rutger Hassink; Pieter A Doevendans; Christine Mummery
Journal:  J Physiol       Date:  2006-09-28       Impact factor: 5.182

5.  ADSCs differentiated into cardiomyocytes in cardiac microenvironment.

Authors:  Yanxia Zhu; Tianqing Liu; Kedong Song; Ruiming Ning; Xuehu Ma; Zhanfeng Cui
Journal:  Mol Cell Biochem       Date:  2008-12-24       Impact factor: 3.396

6.  In vitro and in vivo bioluminescence reporter gene imaging of human embryonic stem cells.

Authors:  Kitchener Wilson; Jin Yu; Andrew Lee; Joseph C Wu
Journal:  J Vis Exp       Date:  2008-05-02       Impact factor: 1.355

7.  Sorting cardiomyocytes: a simple solution after all?

Authors:  Christine Mummery
Journal:  Nat Methods       Date:  2010-01       Impact factor: 28.547

Review 8.  Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications.

Authors:  Hilmar Vidarsson; Johan Hyllner; Peter Sartipy
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

9.  Distinct cardiogenic preferences of two human embryonic stem cell (hESC) lines are imprinted in their proteomes in the pluripotent state.

Authors:  Jennifer C Moore; Jidong Fu; Yau-Chi Chan; Dawei Lin; Ha Tran; Hung-Fat Tse; Ronald A Li
Journal:  Biochem Biophys Res Commun       Date:  2008-05-27       Impact factor: 3.575

10.  Stem cells for heart cell therapies.

Authors:  Donghui Jing; Abhirath Parikh; John M Canty; Emmanuel S Tzanakakis
Journal:  Tissue Eng Part B Rev       Date:  2008-12       Impact factor: 6.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.